Earnings Season Start On The Wrong Foot
Although DNA reported good results & raised Yr 06 guidance, some of its drug sales came in below street expectation. Stock is down 1.7% AMC.
LM is down 9.8% AMC as it guides below consensus. Though its reason for guiding down looks company specific, it may well provide a good excuse for profit taking in the rest of the financial sector which has been on a run lately.
All in, with the overall market looking over extended & losing some upside momentum in the last 2-3 trading sessions, these earnings result is not going to go down well with the market. Get ready your PUT options.
0 Comments:
Post a Comment
<< Home